Evidence map›Paper›PMID 40598896›Full record

ArticleNucleic acids research2025

Loss of DHX36/G4R1, a G4 resolvase, drives genome instability and regulates innate immune gene expression in cancer cells.

Anna R Bartosik, Pei-Chi Hou, Shangming Tang, James P Vaughn, Philip J Smaldino, Aakrosh Ratan, Marty W Mayo, Yuh-Hwa Wang

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Anna R BartosikDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.
Pei-Chi HouDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.
Shangming TangDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.
James P VaughnNanoMedica LLC, Winston-Salem, NC 27106, United States.
Philip J SmaldinoDepartment of Biology, Ball State University, Muncie, IN 47306, United States.
Aakrosh RatanDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.
Marty W MayoDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.
Yuh-Hwa WangDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908-0733, United States.ORCID 0000-0002-9804-9368

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Genomic Architecture of LGL LeukemiaR01CA178393 · NCI · UNIVERSITY OF VIRGINIA · PI Thomas P. Loughran, Aakrosh Ratan · 2016 to 2026
$6.5M
Genome-wide DNA Secondary Structure Analysis to Investigate DNA FragilityR01GM101192 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WANG, YUH-HWA · 2013 to 2024
$2.8M
Implicating the major G-quadruplex helicase, DHX36, as a novel pathogenic modifier of C9ORF72 frontal temporal dementiaR15AG067291 · NIA · BALL STATE UNIVERSITY · PI SMALDINO, PHILIP J · 2020 to 2024
$939k
Disrupting two cancer hallmarks with one target: DHX36, the major G-quadruplex helicaseR15CA252996 · NCI · BALL STATE UNIVERSITY · PI OLESEN, JAMES B · 2020 to 2020
$428k
Comprehensive Cancer CenterMiami Foundation for Cancer ResearchNCINIH R15CA252996NCI NIH HHS L70 CA274898NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA178393NCI NIH HHS R01CA178393NCI NIH HHS R15 CA252996NIA NIH HHS R15 AG067291NIGMS NIH HHS R01 GM101192NIGMS NIH HHS RO1GM101192
6 · The paper itself

Abstract

G-quadruplexes (G4s) are four-stranded alternative secondary structures formed by guanine-rich nucleic acids and are prevalent across the human genome. G4s are enzymatically resolved by specialized helicases. Previous in vitro studies showed that DEAH-box helicase 36 (DHX36/G4R1/RHAU) has the highest specificity and affinity for G4 structures. Here, by mapping genome-wide DNA double-strand breaks (DSBs), we demonstrate that knockout of DHX36 helicase increases DSB enrichment at G4 sites and that the presence of the G4 motif is a significant mediator of genome instability at regulatory regions. The loss of DHX36 corresponds with the significant upregulation of NF-κB transcriptional programs, culminating in the production and secretion of proinflammatory cytokines. Loss of DHX36 expression results in the accumulation of cytoplasmic DNA fragments, an increase in the innate immune signaling stimulator of interferon response cGAMP interactor 1 (STING1) expression, and activation of genes involved in immune response pathways. Importantly, higher levels of DHX36 messenger RNA expression in human B-cell acute lymphoblastic leukemia correlate with improved overall survival relative to lower expression of DHX36, highlighting its critical role in preserving genome integrity at a cellular level and in the context of cancer.

Indexed as

DEAD-box RNA HelicasesGene Expression Regulation, NeoplasticGenomic InstabilityG-QuadruplexesImmunity, InnateNeoplasmsCell Line, TumorDNA Breaks, Double-StrandedHumansMembrane ProteinsNF-kappa BSTING ProteinDEAD-box RNA HelicasesDHX36 protein, humanMembrane ProteinsNF-kappa BSTING1 protein, humanSTING Protein

Identifiers

PMID40598896
PMCPMC12214017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.